Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.98 USD
Change Today -0.08 / -1.32%
Volume 76.0K
ONCS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 5:20 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Punit S. Dhillon

Co-Founder, Chief Executive Officer, President and Director, OncoSec Medical Incorporated
AgeTotal Calculated CompensationThis person is connected to 28 board members in 3 different organizations across 4 different industries.

See Board Relationships
35$903,392
As of Fiscal Year 2014

Background*

Mr. Punit S. Dhillon co-founded OncoSec Medical Incorporated in March 10, 2011 and has been its President and Chief Executive Officer since March 10, 2011. Mr. Dhillon was a Co-Founder of Inbalance Network Inc. He has over 12 years of senior management experience in the biotech industry. He served as Vice President of Finance and Operations of Inovio Pharmaceuticals, Inc. since January 2008. He was responsible for the implementation of Inovio's corporate strategy, including ...

Read Full Background

Corporate Headquarters*

9810 Summers Ridge Road
San Diego, California 92121

United States

Phone: 855-662-6732
Fax: 858-430-3832

Board Members Memberships*

2011-Present
Co-Founder, Chief Executive Officer, President and Director
2014-Present
Director
2015-Present
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Governance & Nomination Committee

Education*

BA
Simon Fraser University

Other Affiliations*

Annual Compensation*

Salary$342,500
Bonus$125,000
Total Annual Compensation$467,500

Stock Options*

Exercisable Options1,284,063
Unexercisable Options1,465,937
Total Number of Options2,750,000

Total Compensation*

Total Annual Cash Compensation$467,500
Total Short Term Compensation$467,500
Total Calculated Compensation$903,392
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONCS:US $5.98 USD -0.08

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOSEC MEDICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.